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The functioning of an arteriovenous ﬁstula (AVF) used for vascular access during hemodialysis has 
been assessed mainly by dilution methods.  Although these techniques indicate the immediate recircula-
tion rate,  the results obtained may not correlate with Kt/V.  In contrast,  the clearance gap (CL-Gap) 
method provides the total recirculation rate per dialysis session and correlates well with Kt/V.  We 
assessed the correlation between Kt/V and CL-Gap as well as the change in radial artery (RA) blood 
ﬂow speed in the ﬁstula before percutaneous transluminal angioplasty (PTA) in 45 patients undergoing 
continuous hemodialysis.  The dialysis dose during the determination of CL-Gap was 1.2 to 1.4 Kt/V.  
Patients with a 10ｵ elevation or more than a 10ｵ relative increase in CL-Gap underwent PTA (n＝
45),  and the values obtained for Kt/V and CL-Gap before PTA were compared with those obtained 
immediately afterward.  The mean RA blood ﬂow speed improved signiﬁcantly (from 52.9 to 97.5cm/
sec) after PTA,  as did Kt/V (1.07 to 1.30) and CL-Gap (14.1ｵ to －0.2ｵ).  A signiﬁcant correlation 
between these diﬀerences was apparent (r＝－0.436 and p＝0.003).  These ﬁndings suggest that calculat-
ing CL-Gap may be useful for determining when PTA is required and for assessing the eﬀectiveness of 
PTA,  toward obtaining better dialysis.
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ercutaneous transluminal angioplasty (PTA) is 
often performed to treat stenotic lesions in an 
arteriovenous ﬁstula (AVF) that is used for vascular 
access for hemodialysis.  However,  there are no 
clearly established criteria for judging when PTA is 
indicated or its eﬀect on the adequacy of dialysis.  
Previously,  it was often assumed that decreasing the 
rate of stenosis occurrence was the most important 
goal of PTA; thus,  morphologic evaluations done 
radiologically were considered the primary assess-
P
Acta Med.  Okayama,  2012
Vol.  66,  No.  6,  pp.  443ﾝ447
CopyrightⒸ 2012 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received May 23, 2011 ; accepted May 14, 2012.
＊Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ7427; Fax : ＋81ﾝ86ﾝ235ﾝ6601
E-mail : ugawat@md.okayama-u.ac.jp (T. Ugawa)
ments for determining whether PTA was necessary or 
eﬀective,  and changes in stenosis were regarded as 
indications that PTA was required or had improved 
the eﬃciency of dialysis eﬃciency [1,  2].
　 The dialysis rate,  or Kt/V,  was recently suggested 
to be a more objective evaluation method for an AVF 
[3-6].  Kt/V,  however,  is associated with multiple 
factors; in addition to urea clearance,  the length of 
dialysis and quantity of blood ﬂow (QB) can aﬀect Kt/
V values.  Because QB depends on the condition of the 
vascular access,  adequate Kt/V values cannot be 
obtained unless the access is functioning well.  
Moreover,  it is diﬃcult to obtain such values when 
there is a high recirculation rate,  even when QB is 
suﬃcient.  Therefore,  it is necessary to include the 
recirculation rate as a factor when performing a com-
prehensive functional evaluation of an AVF.  Various 
methods for determining the recirculation rate have 
been proposed,  but there is no standard technique 
[7-9].
　 Recirculation rate and access function are closely 
correlated,  and it can be assumed that improvements 
in recirculation rate and dialysis eﬃciency parallel 
each other.  Thus,  the use of recirculation rates in 
evaluation of the indications for and eﬀects of PTA 
could be expected to contribute to an objective assess-
ment method.  There are 2 types of recirculation rate:  
the immediate recirculation rate,  which is determined 
by using a hematocrit dilution technique [7,  8],  and 
the total recirculation rate per dialysis session,  which 
is reﬂected by the urea clearance gap (CL-Gap) [9].  
It is not known whether the immediate recirculation 
rate correlates with Kt/V.  However,  to assess the 
functional evaluation of vascular access hematologi-
cally and to assess the recirculation rate and dialysis 
eﬃciency at the same time,  the determination of the 
total recirculation rate per dialysis session may be the 
more appropriate choice.
　 In this study,  we used the clearance gap (CL-Gap) 
method to evaluate the need for and results of PTA,  
focusing on the recirculation rate.
Patients and Methods
　 All patients provided informed consent to their 
participation in this study,  and the study protocol was 
approved by the institutional review board of Shigei 
Medical Research Hospital.
　 Forty-ﬁve patients in our unit underwent creation 
of a radiocephalic AVF.  These patients met the fol-
lowing criteria: they were without heart failure; they 
had a B-type natriuretic peptide (BNP) level ＜283pg/
mL; and they did not fall under New York Heart 
Association (HYHA) category subsequently required 
PTA because of a stenotic lesion between April and 
December 2011.  Before and after PTA,  the Kt/V 
was set at 1.2 to 1.4 and the recirculation rate was 
calculated by the CL-Gap method.
　 The CL-Gap represents the diﬀerence between the 
expected dialysis eﬃciency and the actual dialysis 
eﬃciency; therefore,  it is indicated by the diﬀerence 
between the theoretical clearance value (tCL) on the 
dialysis membrane side and the eﬀective clearance 
(eCL) from the patient.  The method for calculating 
CL-Gap is detailed in Fig.  1 and is summarized as 
follows: CL-Gap (ｵ)＝ (tCL－eCL)/tCL×100.  
The eCL was calculated as K＝V/T×Kt/V [10],  
where K indicates clearance (mL/min),  T indicates 
the length of dialysis (minutes) and V is body ﬂuid 
volume (mL).  V is calculated by using the Watson 
formula [11]＋weight gained; for a man,  this is 
(2.447－0.09516×age＋0.1074×height in cm＋0.3362
×dry weight in kg＋weight gained in kg)×1,000mL;  
for a woman,  this is (－2.097＋0.1069×height in cm
＋0 .2466×dry weight in kg＋weight gained in kg)×
1,000mL.  There is a limitation in calculating tCL:  
urea clearance in vitro,  based on each dialyzer mem-
brane,  is within 200mL/min.  The calculation sheet 
for the CL-Gap formula is available at http://juns.
cool.ne.jp (Fig.  1).
　 PTA was performed when a 10ｵ absolute increase 
in CL-Gap or a 10ｵ relative increase was observed.  
The blood ﬂow speed in the radial artery (RA) was 
measured by angiography with iodine-positive contrast 
medium for patients without an iodine allergy,  or with 
carbon dioxide gas-negative contrast medium for 
patients with an iodine allergy,  and the values for Kt/
V and CL-Gap were calculated both before and after 
PTA.  The same dialysis conditions,  routes of blood 
removal and transmission,  and puncture position were 
used before and after PTA.
　 The carbon dioxide angiographic examination used 
a cardiac catheter test device (Philips Electronics 
Japan,  Tokyo,  Japan),  and carbon dioxide was sup-
plied by a carbon dioxide injector,  GASTER 
(Gadelius Medical,  Tokyo,  Japan).  When carbon 
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dioxide gas is manually injected into a vessel during 
angiography,  the direction of the gas inﬂuences the 
ﬂow speed in the RA; thus,  a diﬀerence in ﬂow speed 
between the upward and downward direction develops.  
To reduce this diﬀerence,  the brachial artery is 
punctured at the cubital fossa with a 22-ga.  elaster 
needle (which is left in place),  and the carbon dioxide 
is injected at 4mL per sec (8-10mL per injection).  
Bubble ﬂow caused by the gas injection is depicted at 
30 frames/sec.  The bubble ﬂow rate was measured at 
the straight segment of the RA and was considered to 
be the RA blood ﬂow speed in the AVF.  The same 
method was used for the iodine angiography.  Iodine 
contrast medium,  Iomeprol,  equivalent to 300mg of 
iodine (Brocco-Eizai Co.,  Tokyo,  Japan) was diluted 
to half concentration with saline,  and injected at 
4mL/sec (8-10mL per injection).
　 Diﬀerences between pre-PTA and post-PTA values 
for RA blood ﬂow speed,  Kt/V,  and CL-Gap were 
assessed by using box-and-whisker plots in the 45 
patients who underwent PTA.  Lastly,  the correlation 
between RA blood ﬂow speed improvement and 
CL-Gap improvement after PTA was analyzed by a 
scatterplot to judge PTA eﬃcacy immediately after the 
PTA.  All of the analyses were conducted by PASW 
version 18.0J (SPSS Japan Inc.  Tokyo,  Japan),  and 
p-values less than 0.05 (two-sided) were considered as 
signiﬁcant.
Results
　 Forty-ﬁve patients were studied: 28 men and 17 
women; mean [± SD] age,  63±11 years; mean dialy-
sis duration,  58±63 months; diabetes,  20 patients 
[44.4ｵ].  The mean (± SD) blood ﬂow speed in the 
RA in the 45 patients who underwent PTA increased 
from 52.9±27.8cm/sec before PTA to 97.5±29.7 
cm/sec after PTA (p＜0.001,  Fig.  2); thus,  the speed 
after the procedure was 2.33 times greater than that 
beforehand.  The mean value for Kt/V increased from 
1.07±0.24 to 1.30±0.15 (p＜0.001,  Fig.  3),  and 
the mean value for CL-Gap (ｵ) decreased from 14.1
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Fig. 1　 Methods for calculating theoretical clear-
ance (tCL),  eﬀective clearance (eCL),  and clearance 
gap (CL-Gap) in patients undergoing hemodialysis.
±14.6ｵ to －0.2±5.4ｵ (p＜0.001,  Fig.  4).  And,  a 
correlation between these diﬀerences was apparent 
(r＝－0 .436 and p＝0.003,  Fig.  5).
　 In the 45 patients who underwent PTA,  the proce-
dure was considered necessary because their Kt/V 
and CL-Gap values indicated a possible deterioration 
in recirculation rate.  Angiography showed that all 
these patients had stenosis,  which was resolved by 
PTA in all cases.
Discussion
　 Although PTA treatment of stenosis in a vascular 
access helps to increase the duration of access pat-
ency,  PTA therapy is often performed without evalu-
ating whether the stenosis is actually causing a dete-
rioration in recirculation rate.  However,  if the 
purpose of PTA is to improve dialysis eﬃciency,  it is 
important to assess the extent to which it is likely to 
fulﬁll this aim before the procedure is done and 
thereby limit PTA treatment to patients with an 
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Fig. 3　 Box-and-whisker plots of pre-PTA and post-PTA values 
for Kt/V (n＝45).  ＊p＜0.001
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Fig. 4　 Box-and-whisker plots of pre-PTA and post-PTA values 
for CL-Gap (n＝45).  ＊＊p＜0.001
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Fig. 5　 A scatterplot between improvements of RA blood ﬂow 
speed and CL-Gap (n＝45).  RA: radial artery.
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Fig. 2　 Box-and-whisker plots of pre-PTA and post-PTA values 
for RA blood ﬂow speed (n＝45).  RA: radial artery.  ＊p＜0.001
inadequate recirculation rate.  The results of the pres-
ent study suggest that a hematologic functional evalu-
ation of the access that is based on Kt/V and CL-Gap 
should be performed.  It is also important to determine 
whether a PTA treatment has improved the recircula-
tion rate and increased dialysis eﬃciency.  If a com-
prehensive functional evaluation of a vascular access 
were reﬂected by the dialysis eﬃciency represented by 
Kt/V,  the assessment would permit good access man-
agement based on the recirculation rate.  However,  
because Kt/V depends on QB,  it is diﬃcult for an 
access with a high recirculation rate to obtain a suﬃ-
ciently high Kt/V,  even if QB is suﬃcient.  QB is 
considered to be maintained when the recirculation is 
evaluated adequately and accurately.  Various methods 
for evaluating recirculation in a vascular access have 
been proposed [7,  8].
　 We previously showed that the CL-Gap,  correlated 
with Kt/V,  indicates the recirculation rate of an 
AVF. [9] In the present study,  the CL-Gap value 
improved signiﬁcantly after PTA,  as did Kt/V and RA 
blood ﬂow speed.  Fig.  5 shows the correlation between 
the CL-Gap and RA diﬀerence in PTA.  This analysis 
showed whether CL-Gap prescribed RA diﬀerence in 
PTA.  The correlation index between the diﬀerences 
in CL-Gap and Kt/V pre- and post-PTA was r＝  
－0.436 and was signiﬁcant (p＝0.003).  CL-Gap is 
measured after hemodialysis,  so PTA eﬃcacy by 
CL-Gap is judged several days after PTA.  RA blood 
ﬂow speed is measured at PTA,  and RA blood ﬂow 
speed improvement is judged immediately after PTA.  
The data in Fig.  5 suggest that the faster that the RA 
blood ﬂow improved after PTA,  the more the recircu-
lation rate (CL-Gap) improved.  Thus we were able to 
assess PTA eﬃcacy immediately after the PTA by 
measuring the RA blood ﬂow speed.  We therefore 
suggest that PTA is necessary for AVFs that show at 
least a 10ｵ increase in absolute CL-Gap or more than 
a 10ｵ relative increase.  This standard can be also 
used to assess the eﬀectiveness of PTA.
　 We studied 45 patients who underwent PTA with 
BNP,  because BNP is a risk factor for cardiac events 
in hemodialysis patients.  Kuno et al.  studied 395 
patients with both BNP＞283pg/mL and Troponin T
＞0.08ng/mL,  and they reported that the patients 
group had a 41.1ｵ risk of mortality and a 52.7ｵ risk 
of cardiac events in the ﬁve-year period after starting 
hemodialysis [12].
　 In summary,  we conclude that CL-Gap is a valid 
index of recirculation rate and that it also indicates 
the dialysis ability of an AVF for vascular access.  
Improvements in dialysis eﬃciency might be obtained 
by focusing on improving RA blood ﬂow speed values 
by performing PTA.
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